Tag Archives: diabetes and hypertension

India wins UN awards for Initiative against Hypertension

Posted on by
Reply

In a significant achievement and recognition to country’s efforts against hypertension, India has won an UN award for its “India Hypertension Control Initiative (IHCI)”, a large-scale hypertension intervention under National Health Mission. IHCI has been recognized for its exceptional work within India’s existing primary healthcare system.

Complimenting the healthcare initiative, Dr. Mansukh Mandaviya, Union Minister of Health & Family Welfare stated in a tweet: “IHCI has strengthened PM @NarendraModi  Ji’s mission to ensure health & wellness for all”. We are committed to building a healthy & fit India, he further noted.

A collaborative initiative of Ministry of Health and Family Welfare, Indian Council of Medical Research (ICMR), State Governments and World Health Organization-India, IHCI has won the ‘2022 UN Interagency Task Force, and WHO Special Programme on Primary Health Care Award’ at the UN General Assembly side event held on 21st September 2022 at New York, USA. The award recognizes outstanding commitment and action of India to: (i) prevent and control Non-Communicable Diseases (NCDs) and (ii) deliver integrated people-centric primary care. The UN Task Force has identified organisation which has multisectoral approach in prevention and control of NCDs and multisectoral action with demonstrated results at primary care for prevention and control of NCDs and related Sustainable Development Goals (SDGs).

ministry of health

Significance of the initiative can be adjudged from the fact that one in four adults in India has high blood pressure. The control of hypertension at primary care system level will contribute  to reducing deaths due to heart attacks, stroke and kidney failures.

IHCI has been able to leverage and strengthen the existing healthcare delivery system, hypertension control interventions under National Health Mission and improve the linkages between populations-based screening initiative with health care.  The initiative was launched in 2017 and expanded in a phased manner to cover more than 130 districts across 23 states. Under the initiative, more than 34 lakh people with hypertension are taking treatment in government health facilities, including Ayushman Bharat Health Wellness Centres (HWCs).  The project strategies are easily scalable within the health system. The strategies include a simple drug-dose-specific standard treatment protocol, ensuring adequate quantity of protocol medications, decentralization of care with follow-up and refills of medicines at Health Wellness Centres, task sharing involving all health staff and a powerful real-time information system which can track every patient for follow-up and blood pressure control. Under IHCI, nearly half of those who were treated had blood pressure under control.

The IHCI complements the National Programme for Prevention and Control of Diabetes, Cardiovascular Disease and Stroke (NPCDCS) of the Ministry of Health & Family Welfare, Government of India. IHCI accelerates the achievement of targets of the Government of India by ensuring a continuum of care and giving a boost to the ongoing “Ayushman Bharat” programme.

BP and diabetes greatest risk factors of death from COVID-19, confirms study; What’s next

Posted on by
Reply

Hospitalized COVID-19 patients have a greater risk of death if they are men or if they are obese or have complications from diabetes or hypertension, confirmed a new study conducted by University of Maryland School of Medicine (UMSOM) researchers after evaluating nearly 67,000 hospitalized COVID-19 patients in 613 hospitals across the US.

In a study published in the journal Clinical Infectious Diseases, the researchers found that men had a 30 percent higher risk of dying compared to women of the same age and health status. Hospitalized patients who were obese, had hypertension or poorly managed diabetes had a higher risk of dying compared to those who did not have these conditions. Those aged 20 to 39 with these conditions had the biggest difference in their risk of dying compared to their healthier peers.

“Predicting which hospitalized COVID-19 patients have the highest risk of dying has taken on urgent importance as cases and hospitalizations in the U.S. continue to surge to record high numbers during the month of December,” said study corresponding author Anthony D. Harris. Professor of Epidemiology and Public Health at UMSOM.

Remdesvir

For example, higher-risk patients may be given the drug remdesivir earlier in their hospitalization to help prevent severe complications or may be considered for closer monitoring or ICU admission. Healthcare providers may also want to consider these risks when determining which COVID-19 patients could benefit the most from the new monoclonal antibody therapies that, if given in the first few days of the infection, can reduce the risk of hospitalization.

Age remained the strongest predictor of mortality from COVID-19. Overall, nearly 19 percent of hospitalized COVID-19 patients died from their infection with the lowest mortality among pediatric patients, which was less than 2 percent. Mortality rates increased with each decade of life with the highest mortality, 34 percent, among those aged 80 and older.

“Older patients still have the highest risk of dying, but younger patients with obesity or hypertension have the highest risk of dying relative to other patients their age without these conditions,” said study lead author Katherine E. Goodman, a postdoctoral fellow in the Department of Epidemiology and Public Health at UMSOM.